Home
Conditions
Bacterial Infections and Mycoses

Clinical trial condition

Bacterial Infections and Mycoses

Explore clinical trials studying Bacterial Infections and Mycoses. Study availability and eligibility vary by location and protocol.

5,904 public trials 637 recruiting studies

Refine in advanced search Browse all conditions

Bacterial Infections and Mycoses trial results

Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

NCT00133848

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Hyderabad, India

GSK Investigational Site Rome, Lazio, Italy

GSK Investigational Site Zapopan, Jalisco, Jalisco, Mexico

View all 22 locations

View Trial Details

Completed

Prospective Assessment of TBDx Feasibility

NCT02912832

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia Lima, Peru

Pham Ngoc Thach Hospital Ho Chi Minh City, Vietnam

View Trial Details

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Eppelheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 51 locations

View Trial Details

Completed

A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test

NCT00682851

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bacterial Vaginosis, +10 more
Locations: Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

NCT00258700

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations: GSK Investigational Site Bydgoszcz, Poland

GSK Investigational Site Gdansk, Poland

GSK Investigational Site Kielce, Poland

GSK Investigational Site Krakow, Poland

View Trial Details

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

NCT00126945

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Aarhus N, Denmark

View Trial Details

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

NCT00196963

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Thuin, Belgium

View Trial Details

Completed

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

NCT00227422

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Beirut, Lebanon

View Trial Details

Completed

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

NCT00263653

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations: GSK Investigational Site Almería, Spain

GSK Investigational Site Almería, Spain

GSK Investigational Site Antequera/Málaga, Spain

GSK Investigational Site Aravaca, Spain

View all 16 locations

View Trial Details

Completed

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

NCT00317122

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +20 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Brits, South Africa

GSK Investigational Site Centurion, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

View Trial Details

Bacterial Infections and Mycoses

Bacterial Infections and Mycoses trial results

Related conditions